Healthcare, Pharma & Life Sciences

Bengaluru – October 08, 2026 -- Omega Healthcare has secured recognition in three separate categories of the 2026 Avtar & Seramount benchmarking studies, one of India's most rigorous assessments of workplace inclusion and wellness, with the AI-driven healthcare solutions company set to collect the awards at Avtar's Best Practices of the Best conference on Nov. 3.

Company enters Hall of Fame after sixth consecutive year on women's workplace list

Omega Healthcare was named to the Best Companies for Women in India (BCWI) list for the sixth straight year, a streak that qualifies it for entry into the BCWI Hall of Fame -- a distinction reserved for organizations ranked five or more years running. The BCWI study, now in its 11th edition, evaluates how organizations help women build careers and move into leadership.

Delray Beach, Fla. – – October 08, 2026 -- The global Active Pharmaceutical Ingredients (API) market will grow from USD 149.02 billion in 2026 to USD 199.42 billion by 2031, a 6.0% compound annual growth rate, according to new data from MarketsandMarkets.

North America commands 43.1% of global API sales as domestic manufacturing investment accelerates

North America held the largest regional share of the API market in 2025 at 43.1%, driven by established pharmaceutical R&D infrastructure and rising investment in domestic production capacity. The US leads regional output in high-value and complex API development, supported by a dense base of pharmaceutical companies, contract manufacturing organizations, and specialized API producers.

Galway – October 08, 2026 -- Medtronic plc has fixed the final exchange ratio for its split-off of MiniMed Group, Inc. at 4.5939 shares of MiniMed common stock for every Medtronic ordinary share tendered and accepted.

Medtronic caps the swap at the upper limit after shares priced above range

The company said the calculated per-share values of both Medtronic ordinary shares and MiniMed common stock, determined under the method set out in MiniMed's SEC-filed Prospectus, would have produced a ratio exceeding the deal's upper limit of 4.5939. Medtronic therefore locked the ratio at that ceiling, the maximum allowed under the offer's terms.

Sarasota – October 08, 2026 -- 360 Orthopedics has become one of the first orthopedic practices in Florida to receive the Center of Excellence (COE) designation for workers' compensation care, a credential tied to measurable standards in access, documentation and return-to-work coordination.

Designation targets delays that drive up claim costs for employers and carriers

The COE evaluation assesses five operational areas: timely orthopedic evaluation and treatment, accurate medical documentation, communication among patients, employers, adjusters and nurse case managers, coordination of authorizations and follow-up care, and structured return-to-work planning. For employers and insurers, process delays in any of these areas can extend time away from work and increase claim complexity and cost.

New York – October 08, 2026 -- Elsevier has signed a strategic content agreement with the JAMA Network to integrate full-text content and visuals from 13 JAMA journals into ClinicalKey AI, its clinical-grade AI workspace, giving clinicians access to more than half of the world's top 100 medical journals through the platform.

Agreement covers 13 JAMA Network titles including flagship journal and specialty publications

The deal brings all published full-text content and visuals from JAMA, JAMA Network Open, and 11 specialty journals -- JAMA Cardiology, JAMA Dermatology, JAMA Health Forum, JAMA Internal Medicine, JAMA Neurology, JAMA Oncology, JAMA Ophthalmology, JAMA Otolaryngology-Head & Neck Surgery, JAMA Pediatrics, JAMA Psychiatry and JAMA Surgery -- into the responses clinicians receive through ClinicalKey AI. Content is available to ClinicalKey AI customers immediately.

Orange County, Calif. – October 08, 2026 -- The Institute for Molecular Medicine (IMM) and Nuravax have dosed the first four participants in TAURUS-1980, a Phase 1 trial testing AV-1980R, described as the world's first active immunotherapy targeting pathological tau protein linked to Alzheimer's disease.

Trial targets at-risk adults before cognitive symptoms appear

TAURUS-1980 will enroll up to 48 cognitively unimpaired adults aged 65 to 80 who have biomarker-confirmed brain amyloid pathology, a known precursor to Alzheimer's. Participants are randomized 3:1 to receive AV-1980R or placebo across three ascending-dose cohorts of 20, 60, and 180 micrograms.

Sarasota, Fla. – October 08, 2026 -- Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) reported that its Bisphosphocin compound Nu-8, delivered intravesically to rodents infected with E. coli, achieved up to 97% inhibition of bacterial growth using a 10% solution, against no effect in a vehicle control group.

Nu-8 targets drug-resistant bacteria linked to catheter-associated UTIs

The Bisphosphocin class has shown in vitro activity against a broad range of resistant bacteria common in urinary tract infections, including E. coli, K. pneumoniae, and P. aeruginosa, and against biofilm-forming organisms. Complicated UTIs, particularly catheter-associated urinary tract infections, are frequently driven by drug-resistant strains and biofilm formation, a persistent challenge for hospital infection control.

Mesa, Ariz. – October 08, 2026 -- Bright Path, a U.S. pharmaceutical manufacturer, has been named a 2026 AZBio Fast Lane Award honoree by the Arizona Bioindustry Association, recognizing milestones reached over the past 18 months including a first-of-its-kind FDA manufacturing designation and committed commercial production of hospital medicines facing chronic shortages. The company was honored at the 23rd Annual AZBio Awards at the Phoenix Convention Center during Arizona Bioscience Week.

Goleta, Calif. – October 08, 2026 -- Vitamin Angels presented new implementation research at the 2026 Micronutrient Forum Global Conference in Accra, Ghana, revealing a sharp gap between access to maternal nutrition supplements and actual completion of recommended courses. In Makueni County, Kenya, formative research found that while 93% of pregnant women surveyed received iron and folic acid supplementation, only 17% completed the recommended 180-day course, even as 95% of pregnant women and 96% of health providers backed multiple micronutrient supplementation (MMS).

Windham, N.H. – October 08, 2026 -- Emergency department volumes in the United States are projected to grow 6% over the next decade, intensifying pressure on an already strained emergency care system, according to a new report from Medicus Healthcare Solutions.

Medicus releases 2026 edition of national emergency medicine workforce report

The locum tenens and healthcare workforce solutions company published "A System Under Strain: Rising Demands in Emergency Medicine," a data-driven analysis combining national statistics, industry research, and proprietary insights into physician staffing patterns.